Lori Handy, MD, provides guidance in these areas including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
|Videos|August 23, 2016
How Can Scientists Neutralize the mcr-1 Gene?
Author(s)Contagion Editorial Staff
Andrea Endimiani, MD, PhD, professor at the Institute for Infectious Diseases at the University of Bern, Switzerland, discusses how scientists can neutralize the mcr-1 gene.
Advertisement
Andrea Endimiani, MD, PhD, professor at the Institute for Infectious Diseases at the University of Bern, Switzerland, discusses how scientists can neutralize the mcr-1 gene.
Interview Transcript (slightly modified for readability)
“This is a very difficult question. At the moment we don’t have anything but [I believe] that in [the] future we will be able to create systems like the CRISPR/Cas9 system to neutralize the genetic production of this [mcr-1] gene. But at the moment, we are unable to neutralize the mechanism of resistance.
[In the future], we will [probably] find new drugs to bypass, to overcome, these system, but at the moment I will say that we don’t have a clear answer.”
Advertisement
Related to this article
Jason Pogue, PharmD, BCPS, BCIDP, contextualizes preliminary data looking at this trial and other extended-spectrum beta-lactamase (ESBL) studies, which reopens the debate around carbapenem-sparing treatment options.
With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after animal interactions as well as clinical treatment when people have been bit or scratched.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
Advertisement
Advertisement
Trending on Contagion Live
1
FAQ: Rising Rabies Exposure Calls PEP Decisions Back in Focus
2
Measles Update: October 2, 2026
3
Clinical Considerations for Measles: Presentation, Treatment, and Hospitalization
4
New IDSA/ESCMID S aureus Bacteremia Consensus Statements: a Risk Stratification Framework
5